// App-Quantinova.ai

P111 : Exploratory Analysis of Filgotinib Safety Data in Patients With Moderately to Severely Active Rheumatoid arthritis and an Increased Risk of Cardiovascular Events: Data From Phase 2 and 3 Clinical Trials

Researchers

Presenter

  • Maya H Buch

Principal Investigators

  • Gerd R Burmester

  • Xavier Mariette

  • Christina Charles-Schoeman

  • Vijay Rajendran

  • Pieter-Jan Stiers

  • Agustin Cerani

  • Paul Van Hoek

  • Katrien van Beneden

  • Yoshiya Tanaka

  • Hendrik Schulze-Koops

  • Rene Westhovens

  • Ennio Favalli

Medical Centers

  • ASST Gaetano Pini - CTO Institute, University of Milan, Milan, Italy

  • UCLA David Geffen School of Medicine, Los Angeles, CA

  • Biostatistics, Galapagos NV, Mechelen, BELGIUM

  • Pathology, University Hospitals Leuven, Leuven, Belgium

  • Division of Neonatology, Ludwig Maximilians University, Munich, Germany

  • Clinical Development, Galapagos NV, Mechelen, Belgium

  • Pharmacovigilance, Galapagos NV, Mechelen, Belgium

  • Rheumatology, Galapagos NV, Mechelen, BELGIUM

  • Global Medical Affairs, Galapagos NV, Mechelen, Belgium

  • Manchester Cancer Research Centre, University of Manchester, Manchester, United Kingdom

  • University of Paris-Saclay, Assistance Publique Hopitaux de Paris, Le Kremlin-Bicêtre, France

  • University of Occupational and Environmental Health, Kitakyushu, Japan

  • Charite Univsmedizin Berlin, Berlin, Germany

Locations

  • Italy

  • Belgium

  • United States

  • United Kingdom

  • France

  • Germany

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Angiology

  • Endocrine/metabolic Diseases (ME)

  • Oncology (ONC)

  • Autoimmune (AI)

  • Blood/haematological Diseases

Disease

  • Peripheral artery disease

  • Venous thrombosis

  • Rheumatoid arthritis

  • Dyslipidemia

  • Hypertension

  • Skin carcinoma

  • Inflammatory Arthritis

  • Diabetes

  • Solid malignancies

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Filgotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved